title: Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma.
authors.forename: Frederik A
authors.initials: FA
authors.lastname: Verburg
authors.forename: Markus
authors.initials: M
authors.lastname: Dietlein
authors.forename: Michael
authors.initials: M
authors.lastname: Lassmann
authors.forename: Markus
authors.initials: M
authors.lastname: Luster
authors.forename: Christoph
authors.initials: C
authors.lastname: Reiners
mesh_terms: D002454:Cell Differentiation; D003131:Combined Modality Therapy; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use*; D009367:Neoplasm Staging; D013964:Thyroid Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery
chemical_list: D007457:Iodine Radioisotopes